PD-1 blockade is also tried in patients with DLBCL, follicular lymphoma, T cell lymphoma, or mycosis fungoides/Sézary syndrome (MF/SS) with variable ORR (30–40%) (NCT01592370 and NCT02243579) [144, 145]. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.